Don’t see what you’re looking for? Use the search box on MDA’s Quest magazine.
Early-stage planning is under way to add US trial sites to an ongoing Israeli stem cell trial in ALS
Posted on Friday, July 22, 2011 - 15:25, By: Amy Madsen
Biotechnology company BrainStorm Cell Therapeutics has announced plans to collaborate with two American institutions to test its experimental stem cell technology in people with amyotrophic lateral sclerosis (ALS) in the United States. The institutions are Massachusetts General Hospital in Boston...